Published in Biotech Business Week, December 20th, 2004
Data from this pivotal trial may be used to support the European submission for consideration of CE Mark approval and commercialization in Europe. The results were announced at the 33rd annual meeting of the American Association of Gynecologic Laparoscopists in San Francisco, California.
The study involves 75 patients in total - randomized 2:1, and was initiated at four...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.